CEO Sharn Barbarin and Abel Morón, MD, celebrating the 5000th robotic surgery procedure with Medical City Arlington colleagues.
Arlington – Medical City Arlington is celebrating the successful completion of its 5000th robotic surgery procedure, more than 11 years since OB-GYN physician Steven Seligman, MD, performed the hospital’s first robotic surgery using a da Vinci robotics platform in January 2012.
Gynecologic oncologist Abel Moron, MD, helped the surgical team surpass 5000 robotic-assisted surgeries. Medical City Arlington’s expanding gynecologic oncology program is part of Sarah Cannon, the Cancer Institute of HCA Healthcare. The program provides comprehensive cancer services with convenient access to leading-edge therapies for people facing cancer in the local community. With a dedicated women’s hospital, Medical City Women’s Hospital Arlington, local patients also can access oncology navigation services, which connect oncology-trained registered nurses with patients for education, guidance and support.
Medical City Arlington now offers four different types of robotics systems to provide advanced care for a variety of minimally invasive surgical procedures. The da Vinci robotics platform is also used for minimally invasive procedures such as heart, colorectal and urologic. In addition, surgeons use the hospital’s Ion robotic-assisted bronchoscopy platform for lung biopsies, the Mako system for hip and knee replacement and the Globus Medical ExcelsiusGPS™ for back, spine and neurological surgeries.
“We continue to expand our robotic surgery technology to enhance patient recovery and safety,” Medical City Arlington CEO Sharn Barbarin says. “Our hospital’s investment in leading-edge technology demonstrates Medical City Arlington’s commitment to providing high-quality healthcare services for our community.”
This year, Medical City Arlington became the first hospital in North Texas to use the Globus robotic surgery navigation system for brain procedures, enhancing surgical accuracy and visualization inside the patient’s body.
“This robotic system allows surgeons to precisely target tiny areas of the brain and spine with the best accuracy possible,” says Medical City Arlington neurosurgeon Gaddum Reddy, MD, PhD, who leads the deep brain stimulation (DBS) program at Medical City Arlington. “Robotic-assisted stereotactic cranial surgery can be much less invasive for patients while enhancing safety and improving recovery time.”
Neurosurgeons pictured include Gaddum Reddy, MD, PhD; Clay Elswick, MD; and Frederick Todd II, MD; all on medical staff at Medical City Arlington.
The new cranial features of the robotic system support stereotactic procedures that integrate imaging, such as MRIs or CT scans, performed shortly before the surgery. The detailed imaging targets and more accurately guides neurosurgeons to the exact brain location for treatment. Procedures may include DBS to help control unwanted motor symptoms of Parkinson’s disease and essential tremors. Other procedures can include brain biopsies and stereoelectroencephalography (SEEG), the surgical implantation of electrodes into the brain to identify locations where epileptic seizures originate.